Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,033Cr
Seeds/Tissue Culture/Bio Technology
Rev Gr TTM
Revenue Growth TTM
-2.85%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

BSHSL
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 20.6 | 14.2 | 60.6 | 10.7 | -15.8 | 34.4 | -16.4 | 67.5 | 52.4 | -2.4 | -4.8 | -15.9 |
| 32 | 104 | 31 | 67 | 27 | 143 | 25 | 118 | 40 | 138 | 23 | 98 |
Operating Profit Operating ProfitCr |
| 9.3 | 11.0 | 8.7 | 12.1 | 11.7 | 8.7 | 10.9 | 7.8 | 13.3 | 10.0 | 15.5 | 8.9 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2 | 11 | 2 | 8 | 3 | 12 | 2 | 9 | 5 | 13 | 2 | 9 |
| 0 | 1 | 0 | 1 | -1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 |
|
Growth YoY PAT Growth YoY% | 38.4 | 44.6 | 82.6 | 3.5 | 63.9 | 4.5 | 31.9 | 30.8 | 34.8 | 10.3 | 8.2 | -14.0 |
| 5.3 | 9.1 | 4.7 | 9.0 | 10.4 | 7.1 | 7.3 | 7.0 | 9.2 | 8.0 | 8.3 | 7.2 |
| 0.2 | 1.0 | 0.1 | 0.7 | 0.3 | 1.1 | 0.2 | 0.8 | 0.4 | 1.2 | 0.2 | 0.7 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | -24.9 | -9.4 | 38.4 | 66.0 | 11.9 | 18.9 | 12.7 | 39.7 | -7.1 |
| 108 | 79 | 70 | 97 | 163 | 178 | 206 | 228 | 326 | 298 |
Operating Profit Operating ProfitCr |
| 1.2 | 4.2 | 5.8 | 5.9 | 5.1 | 7.2 | 9.4 | 11.1 | 9.1 | 10.6 |
Other Income Other IncomeCr | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 3 | 1 |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 5 | 6 | 6 |
Depreciation DepreciationCr | 0 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 2 |
| 1 | 2 | 3 | 3 | 6 | 11 | 18 | 24 | 28 | 29 |
| 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 2 | 2 |
|
| | 38.4 | 76.9 | 27.9 | 117.6 | 81.1 | 59.8 | 32.4 | 18.9 | 0.3 |
| 0.8 | 1.4 | 2.8 | 2.6 | 3.4 | 5.5 | 7.4 | 8.7 | 7.4 | 7.9 |
| 2.5 | 3.1 | 0.2 | 0.3 | 0.5 | 1.0 | 1.6 | 2.1 | 2.5 | 2.6 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 3 | 5 | 7 | 8 | 10 | 10 | 10 | 10 | 10 | 10 |
| 1 | 3 | 14 | 15 | 18 | 29 | 46 | 68 | 94 | 109 |
Current Liabilities Current LiabilitiesCr | 11 | 14 | 15 | 20 | 40 | 57 | 75 | 83 | 116 | 40 |
Non Current Liabilities Non Current LiabilitiesCr | 4 | 8 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 4 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 15 | 24 | 29 | 38 | 64 | 90 | 124 | 154 | 212 | 152 |
Non Current Assets Non Current AssetsCr | 5 | 7 | 10 | 9 | 9 | 8 | 9 | 8 | 9 | 11 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | -2 | -5 | 0 | -8 | -12 | -8 | 12 | -31 |
Investing Cash Flow Investing Cash FlowCr | -3 | -2 | -3 | -1 | -1 | 0 | -3 | -2 | -7 |
Financing Cash Flow Financing Cash FlowCr | 2 | 5 | 7 | 1 | 14 | 7 | 10 | -9 | 38 |
|
Free Cash Flow Free Cash FlowCr | -2 | -5 | -11 | -1 | -9 | -12 | -11 | 11 | -34 |
| 82.2 | -147.4 | -257.4 | -2.2 | -130.3 | -115.2 | -48.0 | 52.0 | -117.9 |
CFO To EBITDA CFO To EBITDA% | 51.5 | -49.8 | -123.5 | -1.0 | -87.2 | -87.8 | -37.4 | 40.6 | -95.1 |
| Financial Year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 845 | 849 | 1,468 | 4,121 | 3,859 | 2,334 | 1,268 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 40.5 | 31.8 | 25.3 | 39.2 | 229.8 | 104.9 | 48.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 11.3 | 8.2 | 8.6 | 21.5 | 16.9 | 9.1 | 3.5 |
Price To Book Price To Book | 0.0 | 0.0 | 4.1 | 3.6 | 5.1 | 10.4 | 68.5 | 29.8 | 12.1 |
| 8.3 | 3.8 | 197.5 | 142.3 | 172.3 | 302.0 | 181.8 | 83.7 | 41.6 |
Profitability Ratios Profitability Ratios |
| 9.3 | 11.7 | 14.5 | 16.6 | 39.8 | 52.8 | 63.4 | 50.8 | 43.4 |
| 1.2 | 4.2 | 5.8 | 5.9 | 5.1 | 7.2 | 9.4 | 11.1 | 9.1 |
| 0.8 | 1.4 | 2.8 | 2.6 | 3.4 | 5.5 | 7.4 | 8.7 | 7.4 |
| 12.4 | 12.2 | 11.3 | 12.3 | 12.5 | 16.4 | 19.1 | 22.3 | 17.4 |
| 18.8 | 14.4 | 10.1 | 11.4 | 20.0 | 26.6 | 29.8 | 28.4 | 25.2 |
| 4.2 | 3.8 | 5.4 | 5.7 | 8.0 | 10.8 | 12.6 | 13.7 | 11.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Bombay Super Hybrid Seeds Limited (**BSHSL**) is a research-driven, integrated agricultural enterprise specializing in the **Production, Processing, and Marketing** of high-yield **Hybrid and GM Seeds**. Headquartered in **Rajkot, Gujarat**, the company has evolved from a regional player into a significant national contender in the Indian seed industry, focusing on enhancing crop productivity through advanced genetics and biotechnology.
---
### **Integrated Seed Production & Contract Farming Model**
BSHSL operates an asset-light, scalable production model designed to mitigate land ownership risks while maintaining high output volumes.
* **Contract Farming Network:** The company manages large-scale agricultural activities through seed production agreements with a vast network of farmers. BSHSL compensates these partners for cultivation expenses based on predefined rate agreements, ensuring a stable supply of raw seeds.
* **Leasing Strategy:** To maintain operational flexibility, the company utilizes **cancellable and renewable operating leases** for its agricultural lands, offices, and warehouses rather than heavy capital investment in land ownership.
* **Quality Control Protocols:** Production is conducted under strict genetic purity and traceability protocols. Multi-stage germination checks are performed at harvest, after processing, and at the final packing stage.
---
### **Product Portfolio & Market Specialization**
The company offers a diverse catalog of over **150+ products** (with a target to reach **190 products** by **2030**) across field and vegetable crops.
* **Dominance in Oilseeds:** BSHSL holds a market-leading position in the edible oilseed segment, particularly **Groundnut and Sesame**. Groundnut seeds alone accounted for **60%** of Total Operating Income in **FY24**.
* **Cereals & Pulses:** The portfolio includes high-yield varieties of wheat, maize, cumin, coriander, and pulses such as **Tur, Urad, and Masoor**.
* **Vegetable Seeds:** Specialized offerings include hybrid varieties for cereals and vegetables, including niche products like **Anti-cancer Korean Cabbage** and **Diabetes-friendly Hot Pepper**.
* **Supply Volume:** The company currently supplies approximately **20,264.758 tons** of seeds annually.
---
### **Infrastructure & Technological Capabilities**
The company’s operations are supported by modern facilities that integrate traditional storage wisdom with cutting-edge processing technology.
| Facility | Details & Capacity |
| :--- | :--- |
| **Processing Unit** | An **85,000 sq. ft.** facility at Kuchiyadad, Rajkot, utilizing **Buhler (Switzerland)** Sortex machinery for precision grading. |
| **Cold Storage** | **10,000+ Metric Tons (MT)** capacity using solar power and a hybrid of ancient and modern temperature control techniques to reduce energy costs. |
| **Research Farm** | **30-acre** DSIR-approved farm in Rajkot dedicated to breeding, multiplication, and multi-location trials. |
| **Warehousing** | Owned and strategic warehouses in **Jaipur, Akola, Indore, and Ahmedabad**. |
| **Distribution** | A network of **1,000+ distributors** and **8 major state depots** covering **22 states**. |
---
### **Research, Development & Global Collaborations**
BSHSL maintains an **In-house R&D Unit** certified by the **DSIR (Ministry of Science and Technology)**, with recognition valid until **March 31, 2027**.
* **Advanced Techniques:** The R&D team utilizes **DNA analysis**, **Genomics**, **CRISPR/Cas9 gene editing**, and **AI-driven data analytics** to develop drought-resistant and bio-fortified varieties.
* **Strategic Partnerships:**
* **International:** Collaborations with **CIMMYT (Mexico)** for maize/wheat, **IRRI** for rice, and **Anseme SPA (Italy)** for coriander.
* **National:** Partnerships with **ICRISAT**, **IARI (New Delhi)**, and various State Agricultural Universities (**JNKVV, JAU, AAU**).
* **Bio-fortification:** Partnered with **Harvest Plus** to access high-zinc wheat varieties and **ICRISAT** for high-oleic acid groundnut varieties.
---
### **Financial Performance & Credit Profile**
The company has demonstrated a consistent upward trajectory in revenue and profitability, though it faces challenges regarding working capital cycles.
**Key Financial Metrics (Consolidated):**
| Metric (₹ in Crore) | FY23 (Audited) | FY24 (Audited) | FY25 (Estimated) |
| :--- | :--- | :--- | :--- |
| **Total Operating Income** | **228.31** | **257.28** | **358.76** |
| **PAT** | **16.78** | **22.22** | **26.41** |
| **Overall Gearing** | **0.94x** | **0.61x** | **-** |
| **Interest Coverage** | **7.22x** | **6.30x** | **-** |
| **Total Equity** | **-** | **78.28** | **104.68** |
* **Credit Ratings:** As of April 2025, **CARE Ratings** assigned a **CARE BBB; Stable / CARE A3+** rating. However, a subsequent update in **March 2026** moved the company to the **"ISSUER NOT COOPERATING"** category with a revised rating of **CARE BBB-; Stable** due to information delays.
* **Capital Structure:** Shareholders approved an increased borrowing limit of **₹500 Crore** to fund aggressive expansion.
---
### **Strategic Growth Roadmap: "Vision 2030"**
BSHSL aims to become a PAN-India leader by the end of the decade through the following initiatives:
* **Geographic Expansion:** Targeting a presence in **28 States** and **742 Districts** (up from 22 states currently).
* **Infrastructure Growth:** Recent acquisition of a **504 sq. mtr.** facility in **Akola, Maharashtra** (Sept 2024) to optimize inventory.
* **Revenue Targets:** The company has set an ambitious turnover target of **₹60.00 – ₹62.00 Crore** for the specific expansion segment by **FY28**, contributing to a much larger consolidated group turnover.
* **Export Ambition:** Exploring markets in **Asia, Africa, and Latin America** by aligning with international phytosanitary standards.
---
### **Risk Factors & Mitigation**
Investors should monitor the following operational and regulatory risks:
* **Concentration Risk:** High revenue dependency on **Groundnut (60%)** and three primary states (**Gujarat, Maharashtra, Rajasthan** accounting for **88%** of income).
* **Working Capital Intensity:** The operating cycle elongated to **203 days** in **FY24** due to high inventory requirements (**206 days**) to buffer against monsoon volatility.
* **Regulatory & Compliance:**
* **Labour Codes:** Auditors have issued a **qualified opinion** regarding the unquantified impact of the **four New Labour Codes** effective late 2025.
* **Related Party Exposure:** Significant transactions occur with group entities like **Upsurge Seeds of Agriculture Limited** (caps up to **₹300 Crore**) and **American Genetics Seeds Limited**.
* **Environmental Dependency:** Vulnerability to unpredictable rainfall patterns, pest outbreaks, and climate change remains the primary systemic risk.